Managing Ocular Surface Disease - Poll - MDSpire

Managing Ocular Surface Disease

Early recognition of ocular surface disease may enable timely intervention with medications, procedures, and homecare practices, which may limit ocular surface damage and reduce patient symptom severity.

  • By

  • FRANK W. BOWDEN III, MD, FACS

  • October 1, 2025

  • 6 min

Share

Original Source(s)

Managing Ocular Surface Disease

  • by FRANK W. BOWDEN III, MD, FACS

  • October 1, 2025

Related Content

Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel

Novel therapy for dry eye market

  • February 10, 2026

  • 2 min
Elevating Ocular Surface Care

The trilayer decellularized basement membrane is used in ocular surgery and in OSD applications, including corneal and conjunctival-related injuries or defects.

A Vision for Growth

Capital, innovation, and the next wave of ophthalmic breakthroughs